Pulmonary Nodule Management

Definition and Classification

A pulmonary nodule is a well-circumscribed, rounded radiographic opacity up to 3 cm in diameter, completely surrounded by aerated lung parenchyma, without associated atelectasis, hilar enlargement, or pleural effusion, as defined by the American College of Chest Physicians 1, 2
The American College of Chest Physicians classifies lesions larger than 3 cm as pulmonary masses, which are presumed to be bronchogenic carcinoma until proven otherwise 3

For any indeterminate nodule detected on chest radiography, previous imaging should be reviewed first to assess stability, as recommended by the British Thoracic Society 7, 6
A stable nodule for at least 2 years suggests benignity and may not require further follow-up, according to the American College of Chest Physicians 6
The American College of Chest Physicians recommends performing low-dose, non-contrast chest CT to fully characterize the nodule 7, 5, 4

For nodules ≥8 mm or ≥300 mm³, validated prediction models like the Brock model should be used to evaluate the probability of malignancy, as suggested by the American College of Chest Physicians 8
The American College of Chest Physicians identifies advanced age, history of smoking, and history of previous malignancy as clinical risk factors for malignancy 6, 8
The American College of Chest Physicians lists spiculated or lobulated borders, pleural indentation, and upper lobe location as high-risk radiologic characteristics 6, 8

For solid nodules <6 mm without risk factors, no follow-up is required, as recommended by the American College of Chest Physicians 5, 8
For solid nodules 6-8 mm without risk factors, CT follow-up at 12 months is recommended, with no further follow-up if no changes are seen, according to the American College of Chest Physicians 5, 8
For solid nodules >8 mm, the Brock model should be used to calculate the probability of malignancy and determine the next step, as suggested by the American College of Chest Physicians 8
For subsolid nodules, special management is required due to their indolent course and high association with adenocarcinoma, as recommended by the American College of Chest Physicians 6, 1

The American College of Chest Physicians recommends percutaneous or bronchoscopic biopsy for discordant clinical probability and imaging findings, suspected benign diagnosis requiring specific medical treatment, or patient desire for histological confirmation before surgery 5, 8
For nodules ≥8 mm, percutaneous biopsy is generally appropriate when the result will alter management, as suggested by the American College of Chest Physicians 8

For benign nodules that decrease in size but do not completely disappear, follow-up until resolution or lack of growth for 2 years is recommended, according to the American College of Chest Physicians 5
For indeterminate solid nodules showing clear evidence of malignant growth on serial imaging, biopsy or surgical resection is recommended unless contraindicated, as suggested by the American College of Chest Physicians 5